Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.53 |
| ▸ | ITGAV | P06756 | 19/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.53 |
| ▸ | ITGB1 | P05556 | 6/20 | 0.53 |
| ▸ | ITGA5 | P08648 | 6/20 | 0.53 |
| ▸ | ITGB5 | P18084 | 6/20 | 0.53 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7455915 | 1.00 | ITGB3 (0.53) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7447593 | 0.83 | ITGB3 (0.64) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7455287 | 0.81 | ACKR3 (0.46) | ACKR3 | |
| SCHEMBL7455289 | 0.81 | ACKR3 (0.46) | ACKR3 | |
| SCHEMBL7452431 | 0.80 | ACKR3 (0.43) | ITGB3ITGAVACKR3 | |
| SCHEMBL7446807 | 0.78 | ITGAV (0.62) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7447596 | 0.77 | ITGAV (0.64) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7447358 | 0.77 | ITGAV (0.56) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7455550 | 0.74 | ITGAV (0.51) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7455544 | 0.74 | ITGAV (0.51) | ITGB3ITGAVITGA2BITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6274620-B1 | 2-BENZENESULFONYLAMINO-3-((5-BROMO-THIOPHENE-2-CARBONYL)-AMINO )PROPIONIC ACID-TERT-BUTYL ESTERS AS ANGIOGENESIS INHIBITORS; ANTICARCINOGENIC AGENTS; OSTEOPOROSIS, RESTENOSIS, AND OCULAR NEOVASCULARIZATION | BIOCHEM PHARMA INC. (CA) | 2001-08-14 | — | — | US | disclosed |